Connexin Therapeutics is developing small molecule drugs which protect and preserve vision in glaucoma, retinopathies, and various corneal conditions. We are raising our Seed Round of £10 million to advance our programs into IND.
View Top Employees from Connexin Therapeutics Ltd.Website | https://connexintx.co.uk |
Employees | 2 (1 on RocketReach) |
Founded | 2018 |
Industry | Biotechnology Research, Drug Discovery, Pharmaceuticals |
Looking for a particular Connexin Therapeutics Ltd. employee's phone or email?
Carlos Velez is the CEO of Connexin Therapeutics Ltd..
1 people are employed at Connexin Therapeutics Ltd..